Oxazepam: Uses, Dosage & Side Effects
Benzodiazepine anxiolytic — prescription medication for anxiety, insomnia, and alcohol withdrawal
Oxazepam is a short-to-intermediate-acting benzodiazepine prescribed for the management of anxiety disorders, insomnia associated with nervous conditions, and alcohol withdrawal symptoms. It works by enhancing the effect of GABA, a natural calming chemical in the brain. Oxazepam is considered one of the safer benzodiazepines for elderly patients and those with liver impairment because it does not produce active metabolites. Like all benzodiazepines, it carries a risk of dependence and should be used for the shortest duration possible.
Quick Facts
Key Takeaways
- Oxazepam is a benzodiazepine used to treat anxiety, insomnia, and alcohol withdrawal symptoms by enhancing GABA activity in the brain.
- It has a shorter half-life (5–15 hours) and no active metabolites, making it safer for elderly patients and those with liver impairment compared to many other benzodiazepines.
- Risk of dependence increases with higher doses and longer treatment duration — treatment should typically not exceed 2–4 weeks.
- Never stop oxazepam abruptly; gradual dose reduction under medical supervision is essential to avoid potentially life-threatening withdrawal symptoms including seizures.
- Combining oxazepam with opioids, alcohol, or other CNS depressants can cause fatal respiratory depression and must be avoided.
What Is Oxazepam and What Is It Used For?
Oxazepam belongs to the benzodiazepine class of medications, which are among the most widely prescribed psychoactive drugs worldwide. It contains the active substance oxazepam and works by binding to specific sites on the gamma-aminobutyric acid type A (GABA-A) receptor complex in the central nervous system. By enhancing the inhibitory effects of GABA — the brain's primary calming neurotransmitter — oxazepam produces anxiolytic (anti-anxiety), sedative, hypnotic, and muscle relaxant effects.
From a pharmacological perspective, oxazepam is distinguished from many other benzodiazepines by its relatively short half-life of 5 to 15 hours and the absence of pharmacologically active metabolites. Unlike diazepam or chlordiazepoxide, oxazepam is metabolized primarily through direct glucuronidation in the liver, a process that is relatively well preserved in elderly patients and those with hepatic impairment. This pharmacokinetic profile makes oxazepam a preferred choice in these populations, as it is less likely to accumulate and cause prolonged sedation.
Approved Indications
Oxazepam is approved for several clinical indications. It is most commonly prescribed for the symptomatic relief of anxiety, tension, and agitation, whether these symptoms occur as a primary condition or as part of another medical or psychiatric disorder. Insomnia that is associated with anxiety or nervous conditions also responds well to oxazepam treatment. Additionally, oxazepam plays an important role in the management of alcohol withdrawal syndrome, where it helps control symptoms such as confusion, anxiety, tension, and agitation.
When combined with antidepressant therapy, oxazepam can be useful in treating depression that features prominent anxiety symptoms. In such cases, the benzodiazepine provides rapid relief of anxiety while the antidepressant takes effect over several weeks. However, combined therapy should be monitored carefully and the oxazepam component discontinued as soon as clinically appropriate.
It is important to note that oxazepam is intended exclusively for short-term use. International guidelines from the World Health Organization (WHO), the European Medicines Agency (EMA), and the National Institute for Health and Care Excellence (NICE) consistently recommend that benzodiazepine treatment should not exceed 2 to 4 weeks, including the tapering period. Prolonged use increases the risk of tolerance, dependence, and withdrawal complications.
What Should You Know Before Taking Oxazepam?
Before starting treatment with oxazepam, it is essential to have a thorough discussion with your prescribing physician about your complete medical history, current medications, and any substance use patterns. Several conditions and circumstances require special caution or may preclude the use of this medication entirely.
Contraindications
Oxazepam must not be used under the following circumstances:
- Allergy to oxazepam or any excipient: If you have a known hypersensitivity to oxazepam, other benzodiazepines, or any of the inactive ingredients in the formulation (including wheat starch and lactose), do not use this medication.
- Sleep apnea syndrome: Oxazepam is strictly contraindicated in patients with obstructive sleep apnea, as the medication's respiratory depressant effects can worsen airway obstruction during sleep, potentially leading to fatal respiratory arrest.
- Severe respiratory insufficiency: Patients with significantly compromised respiratory function should not use benzodiazepines due to the risk of further respiratory depression.
- Myasthenia gravis: This autoimmune condition causes muscle weakness, and benzodiazepines can exacerbate this weakness, particularly affecting the muscles involved in breathing.
Warnings and Precautions
Several medical conditions and situations require extra caution when using oxazepam. Discuss the following with your healthcare provider before starting treatment:
Use of benzodiazepines, including oxazepam, can lead to physical and psychological dependence. The risk increases with higher doses, longer treatment duration, and in patients with a history of alcohol or drug abuse. Treatment should be kept as short as possible, and a plan for discontinuation should be agreed upon before starting treatment.
Elderly patients: Older adults are more sensitive to the central nervous system effects of benzodiazepines, and confusion is more likely to occur, particularly at higher doses. Reduced doses are recommended, and careful monitoring is essential. The increased risk of falls and hip fractures in elderly benzodiazepine users is well documented in the medical literature and is a significant concern.
Liver and kidney impairment: While oxazepam is generally considered safer than many benzodiazepines in patients with hepatic impairment (because it is metabolized by glucuronidation rather than oxidative metabolism), caution is still warranted. Patients with significant liver or kidney disease may experience altered drug metabolism and should be monitored closely.
History of substance abuse: Individuals with current or previous alcohol, drug, or medication abuse are at significantly higher risk of developing benzodiazepine dependence. If treatment with oxazepam is deemed necessary in these patients, it should be undertaken with extreme caution and under close supervision.
Psychiatric conditions: If you are already taking other medications for mental health conditions — including antidepressants, antipsychotics, other anxiolytics, or sleep medications — inform your prescriber. Combining multiple CNS-active medications increases the risk of excessive sedation and other adverse effects.
Pregnancy and Breastfeeding
Pregnancy: Oxazepam should be avoided during pregnancy unless the benefit clearly outweighs the potential risk to the fetus. Benzodiazepines taken during the first trimester have been associated with an increased risk of congenital malformations, though the evidence is not conclusive. When used during late pregnancy or labor, benzodiazepines can cause neonatal withdrawal symptoms (known as "floppy infant syndrome"), respiratory depression, and feeding difficulties in the newborn. If you are pregnant or planning to become pregnant, consult your healthcare provider immediately about alternative treatments.
Breastfeeding: Oxazepam is excreted in breast milk, although generally in small amounts. While significant adverse effects on the nursing infant are unlikely at therapeutic doses, caution is advised. Symptoms to watch for in the breastfed infant include sedation, poor feeding, and impaired weight gain. Always consult with your healthcare provider before using oxazepam while breastfeeding.
Driving and Operating Machinery
Oxazepam can significantly impair your ability to drive, operate machinery, or perform tasks requiring mental alertness. The medication may cause drowsiness, dizziness, hallucinations, and reduced reaction time. These effects may persist beyond the period of perceived impairment, particularly in the morning following an evening dose. Patients should be advised not to drive or operate dangerous machinery until they know how oxazepam affects them.
Some formulations of oxazepam tablets contain wheat starch and lactose monohydrate as inactive ingredients. The amount of gluten from wheat starch is extremely small (no more than 2.75 to 7.0 micrograms per tablet, depending on the strength) and is very unlikely to cause problems in patients with celiac disease. However, patients with a wheat allergy (distinct from gluten intolerance) should not use these formulations. If you are lactose intolerant, consult your doctor before using this medication.
How Does Oxazepam Interact with Other Drugs?
Drug interactions with oxazepam can range from clinically insignificant to life-threatening. Because oxazepam acts as a central nervous system depressant, combining it with other substances that depress brain activity can have additive or synergistic effects, potentially causing dangerous levels of sedation, respiratory depression, or death. Understanding these interactions is critical for safe medication use.
Major Interactions (Potentially Fatal)
Concurrent use of benzodiazepines and opioids can result in profound sedation, respiratory depression, coma, and death. This combination should only be considered when alternative treatment options are inadequate. If co-prescribed, the lowest effective doses and shortest possible duration of concomitant therapy should be used. Both the FDA and EMA have issued boxed warnings about this combination.
| Drug / Drug Class | Interaction Effect | Risk Level |
|---|---|---|
| Opioid analgesics (morphine, codeine, tramadol, fentanyl) | Profound sedation, respiratory depression, coma, death | Critical |
| Buprenorphine / methadone (opioid substitution therapy) | Fatal respiratory arrest; well-documented in forensic literature | Critical |
| Alcohol (ethanol) | Potentiated sedation, impaired judgment, respiratory depression | Critical |
| Other benzodiazepines / sedatives (zolpidem, zopiclone) | Additive CNS depression, excessive sedation | High |
| General anesthetics | Enhanced and prolonged anesthetic effects | High |
Other Notable Interactions
| Drug / Drug Class | Interaction Effect | Clinical Significance |
|---|---|---|
| Antipsychotics (haloperidol, quetiapine, olanzapine) | Increased sedation, risk of respiratory depression | Moderate |
| Antiepileptics (valproate, carbamazepine, phenytoin) | Additive CNS depression; possible altered seizure threshold | Moderate |
| Tricyclic antidepressants (amitriptyline, nortriptyline) | Enhanced sedation, psychomotor impairment | Moderate |
| Oral contraceptives | May inhibit glucuronidation, potentially increasing oxazepam levels | Low–Moderate |
| Antihistamines (diphenhydramine, promethazine) | Additive sedation and drowsiness | Low–Moderate |
This is not an exhaustive list of interactions. Always inform your healthcare provider and pharmacist about every medication you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Some herbal products, such as valerian root, kava, and St. John's wort, can also interact with benzodiazepines.
What Is the Correct Dosage of Oxazepam?
The dosage of oxazepam must always be individualized based on the patient's condition, age, weight, and response to treatment. Your physician will determine the appropriate dose and duration for your specific situation. The guiding principle is to use the lowest effective dose for the shortest possible time, thereby minimizing the risk of dependence and other adverse effects.
Adults
Anxiety and Tension (Mild to Moderate)
10–15 mg, three to four times daily. This range is appropriate for patients experiencing moderate anxiety symptoms that require pharmacological management.
Severe Anxiety and Agitation
15–30 mg, three to four times daily. Higher doses within this range should be reserved for patients with severe symptoms and used with close medical monitoring.
Insomnia Associated with Anxiety
15–25 mg at bedtime. A single dose before sleep can help manage insomnia related to anxiety or nervous conditions. This should be a short-term solution while addressing the underlying cause.
Alcohol Withdrawal
15–30 mg, three to four times daily, adjusted according to severity of withdrawal symptoms. Alcohol withdrawal management should always occur under direct medical supervision, preferably in a clinical setting.
Elderly Patients
Elderly patients are more susceptible to the effects of benzodiazepines and should begin treatment with reduced doses. A typical starting dose is 10 to 15 mg, two to three times daily. The dose may be increased cautiously if needed, but should generally not exceed the minimum effective dose. Confusion, ataxia, and over-sedation are more common in older adults, and the risk of falls and fractures is significantly elevated.
Children and Adolescents
The safety and efficacy of oxazepam in children under 18 years of age have not been established. Oxazepam should not be given to children or adolescents unless a physician has specifically determined that the potential benefits outweigh the risks. If prescribed, the treatment duration should be as short as possible.
Missed Dose
If you miss a dose of oxazepam, take it as soon as you remember unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Never take a double dose to compensate for a missed one. If you are unsure about what to do, contact your doctor or pharmacist for guidance.
Overdose
If you or someone else has taken too much oxazepam, seek emergency medical attention immediately by calling your local emergency number or poison control center. Take the medication packaging with you to the hospital so that healthcare providers know exactly what was ingested.
Symptoms of oxazepam overdose may include difficulty coordinating movements (ataxia), dizziness, slurred speech, severe muscle weakness, extreme drowsiness or loss of consciousness, agitation, aggression, hallucinations, pupil changes (dilation or constriction), respiratory depression, low blood pressure, rapid heart rate, low body temperature, and nausea or vomiting. Benzodiazepine overdose is particularly dangerous when combined with alcohol or other CNS depressants, as the risk of fatal respiratory depression is greatly increased. The specific benzodiazepine antagonist flumazenil may be used in a hospital setting to reverse the effects, although its use requires careful consideration due to the risk of precipitating seizures.
Stopping Treatment
Never stop taking oxazepam suddenly without consulting your doctor. Abrupt discontinuation after prolonged use can trigger withdrawal symptoms that range from mild (headache, insomnia, irritability, mild depression) to severe and potentially life-threatening (muscle cramps, vomiting, sweating, tremors, delirium, hallucinations, psychosis, seizures, and in rare cases, suicidal ideation). The dose should always be reduced gradually over a period of weeks to months, depending on the duration and level of treatment. Your physician will create a personalized tapering schedule to safely reduce your dose.
What Are the Side Effects of Oxazepam?
Like all medications, oxazepam can cause side effects, although not everyone will experience them. Side effects are generally dose-dependent, meaning they are more likely to occur at higher doses. Elderly patients are particularly sensitive to the effects of benzodiazepines and may experience side effects at lower doses than younger adults.
The following classification uses standard frequency categories defined by the European Medicines Agency: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (<1/1,000), and not known (frequency cannot be estimated from available data).
Common
Affects up to 1 in 10 patients
- Drowsiness and sedation (occurs in approximately 10–15% of patients but typically diminishes after the first few days of treatment)
Uncommon
Affects up to 1 in 100 patients
- Headache
- Dizziness and lightheadedness
- Impaired coordination (ataxia)
- Muscle weakness
- Anterograde amnesia (memory gaps), particularly at higher doses
Rare
Affects up to 1 in 1,000 patients
- Allergic skin reactions (rash, urticaria)
- Respiratory depression (difficulty breathing)
- Paradoxical reactions: insomnia, nightmares, agitation, aggression, hallucinations (seeing or hearing things that are not there)
Frequency Not Known
Reported but frequency cannot be estimated
- Drug dependence and substance use disorder
- Withdrawal syndrome upon discontinuation
- Rebound anxiety (temporary worsening of symptoms after stopping)
In some patients, benzodiazepines can cause paradoxical reactions, meaning the opposite of the intended effect. Instead of calming, the medication may cause increased agitation, irritability, aggression, hostility, nightmares, hallucinations, or psychotic episodes. These reactions are more common in children, elderly patients, and individuals with underlying psychiatric conditions. If you experience any paradoxical reactions, contact your healthcare provider immediately, as the medication may need to be discontinued.
Tolerance: With continuous use, you may notice a reduced therapeutic effect of oxazepam (tolerance development). This is a normal pharmacological phenomenon and is one of the key reasons why benzodiazepine treatment should be time-limited. Do not increase your dose without consulting your doctor, as this increases the risk of dependence.
Reporting side effects: If you experience any side effects, whether listed here or not, please report them to your healthcare provider. Reporting suspected adverse reactions contributes to the ongoing monitoring of the medication's benefit-risk balance. You can also report side effects directly to your national pharmacovigilance authority (such as the FDA MedWatch program in the United States, the Yellow Card Scheme in the United Kingdom, or the EMA EudraVigilance system in the European Union).
How Should You Store Oxazepam?
Proper storage of oxazepam is essential for maintaining the medication's effectiveness and preventing accidental or intentional misuse. Because oxazepam is a controlled substance with abuse potential, extra precautions regarding its storage and security are warranted.
- Temperature: Store at room temperature (15–25°C / 59–77°F) unless otherwise specified on the packaging.
- Light and moisture: Keep the medication in its original packaging to protect it from light and moisture.
- Child safety: Store oxazepam out of sight and reach of children. Consider using a locked medicine cabinet, as accidental ingestion by children can be extremely dangerous.
- Security: Because oxazepam is a controlled substance, store it in a secure location to prevent unauthorized access, theft, or diversion. Do not share your medication with family members, friends, or others.
- Expiration: Do not use the medication after the expiration date printed on the packaging (marked as "EXP"). The expiration date refers to the last day of the stated month.
- Disposal: Do not dispose of unused or expired medication in household waste or down the drain. Return it to your pharmacy for safe disposal, as improper disposal can harm the environment and poses a risk of accidental or intentional misuse.
What Does Oxazepam Contain?
Understanding the full composition of your medication is important, particularly if you have allergies or dietary restrictions. Below is a complete list of the ingredients found in standard oxazepam tablet formulations.
Active Ingredient
The active substance is oxazepam, present in the following tablet strengths:
- 5 mg tablets — white, round, flat, 6 mm diameter
- 10 mg tablets — white, round, flat, 7 mm diameter
- 15 mg tablets — white, round, flat, 8 mm diameter
- 25 mg tablets — white, round, flat, 9 mm diameter
Inactive Ingredients (Excipients)
- Lactose monohydrate: A sugar-based filler. Patients with lactose intolerance should consult their physician before use.
- Wheat starch: Contains trace amounts of gluten (2.75–7.0 micrograms per tablet). This extremely low amount is very unlikely to affect patients with celiac disease, but patients with wheat allergy (distinct from gluten intolerance) should avoid this formulation.
- Pregelatinized maize starch: A binding and disintegrating agent derived from corn.
- Microcrystalline cellulose: A common pharmaceutical excipient used as a filler and binder.
- Magnesium stearate: A lubricant that prevents tablets from sticking to manufacturing equipment.
The tablets are scored but the score line is not intended for splitting the tablet into equal doses. Always take the tablet strength prescribed by your physician. Tablets are available in plastic containers (25, 100, 250, and 500 tablets) and blister packs (25, 50, and 100 tablets), although not all pack sizes may be marketed in every country.
Frequently Asked Questions About Oxazepam
Yes, oxazepam can be addictive. Like all benzodiazepines, oxazepam carries a risk of physical and psychological dependence, particularly with prolonged use or at higher doses. The risk is greater in individuals with a history of alcohol, drug, or medication abuse. To minimize the risk of dependence, treatment with oxazepam should be kept as short as possible — typically no more than 2 to 4 weeks, including the tapering period. When discontinuing, the dose should always be reduced gradually under medical supervision to prevent withdrawal symptoms.
Oxazepam typically begins to take effect within 30 to 60 minutes after oral administration. It is classified as an intermediate-acting benzodiazepine with a somewhat slower onset of action compared to faster-acting alternatives like diazepam or alprazolam. The anxiolytic and sedative effects generally last 6 to 12 hours, depending on the dose and individual metabolism. Because of its slower onset, oxazepam is less associated with the immediate "rush" that contributes to abuse potential with some other benzodiazepines.
No, alcohol must be strictly avoided while taking oxazepam. Both oxazepam and alcohol are central nervous system depressants, and their combined effects can be far greater than the sum of their individual effects. Drinking alcohol while on oxazepam significantly increases the risk of excessive sedation, dangerous respiratory depression, loss of consciousness, and potentially fatal outcomes. Even moderate amounts of alcohol can dangerously amplify the effects of oxazepam. This applies to all forms of alcoholic beverages, including beer, wine, and spirits.
Withdrawal symptoms from oxazepam can range from mild discomfort to life-threatening medical emergencies. Milder symptoms include headache, insomnia, anxiety, irritability, mild depression, and restlessness. More severe symptoms can include muscle cramps and pain, stomach cramps, excessive sweating, tremors, nausea, vomiting, and palpitations. The most serious withdrawal reactions include delirium tremens (confusion, severe tremors, hallucinations), seizures, psychosis, depersonalization, numbness and tingling in the extremities, extreme sensitivity to light, sound, and touch, and in rare cases, suicidal ideation. These severe symptoms are more likely when high doses are discontinued abruptly. To minimize withdrawal risk, doses should always be tapered gradually under medical supervision over several weeks or months.
Oxazepam is often considered one of the safer benzodiazepine options for elderly patients, primarily because it has a relatively short half-life (5–15 hours) and does not produce active metabolites, which reduces the risk of drug accumulation in the body. This is in contrast to longer-acting benzodiazepines like diazepam, which can accumulate over days in elderly patients. However, "safer" does not mean "safe" — elderly patients remain significantly more sensitive to all benzodiazepine effects, including excessive sedation, confusion, cognitive impairment, and increased fall risk. Lower starting doses (typically 10–15 mg two to three times daily) are recommended, and the treatment duration should be kept as short as possible.
Oxazepam should generally be avoided during pregnancy due to potential risks to the developing fetus. Benzodiazepines taken during the first trimester have been associated with a possible increase in congenital malformations, though data are conflicting. Use during late pregnancy or labor can cause neonatal complications including "floppy infant syndrome" (hypotonia, hypothermia, respiratory depression, poor feeding) and withdrawal symptoms in the newborn. If you are pregnant or planning to become pregnant, discuss your treatment options with your healthcare provider immediately. There may be safer alternatives available for managing anxiety during pregnancy, such as certain forms of psychotherapy or medications with better-established safety profiles.
While both are benzodiazepines, oxazepam and diazepam differ in several clinically important ways. Oxazepam has a shorter half-life (5–15 hours versus 20–100 hours for diazepam), a slower onset of action, and crucially, does not produce active metabolites. Diazepam is metabolized into nordiazepam, temazepam, and oxazepam itself — all pharmacologically active — which means its effects can persist for days. This makes oxazepam a preferred choice for elderly patients and those with liver disease, where drug accumulation is a concern. Diazepam, on the other hand, offers faster onset of anxiolysis and is better suited for acute conditions like status epilepticus due to its rapid distribution into the brain.
References and Sources
This article is based on internationally recognized medical guidelines and peer-reviewed scientific sources. All claims are supported by evidence level 1A where available.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List, 2023. Geneva: WHO; 2023. Available from: who.int
- European Medicines Agency (EMA). Benzodiazepines – Summary of Product Characteristics Guidelines. Amsterdam: EMA; 2024.
- National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. Updated 2020. Available from: nice.org.uk
- British National Formulary (BNF). Oxazepam – Drug Monograph. London: BMJ Group and Pharmaceutical Press; 2025.
- U.S. Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines. 2016 (updated 2020). Available from: fda.gov
- Ashton CH. Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual). Newcastle University; 2002 (revised 2024). A comprehensive resource on benzodiazepine pharmacology and tapering protocols.
- Greenblatt DJ, et al. Clinical pharmacokinetics of oxazepam and lorazepam. Clinical Pharmacokinetics. 1981;6(2):89-105. doi:10.2165/00003088-198106020-00001
- Lader M. Benzodiazepine harm: how can it be reduced? British Journal of Clinical Pharmacology. 2014;77(2):295-301. doi:10.1111/bcp.12202
- Soyka M. Treatment of Benzodiazepine Dependence. New England Journal of Medicine. 2017;376(12):1147-1157. doi:10.1056/NEJMra1611832
- Bachhuber MA, et al. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013. American Journal of Public Health. 2016;106(4):686-688. doi:10.2105/AJPH.2016.303061
Editorial Team & Medical Review
All medical content on iMedic is created and reviewed by qualified healthcare professionals following international guidelines and the GRADE evidence framework.
Licensed physicians specializing in clinical pharmacology, psychiatry, and internal medicine with extensive experience in drug safety and evidence-based prescribing.
Independent panel of medical specialists who verify accuracy, completeness, and adherence to current international guidelines (WHO, EMA, FDA, BNF, NICE).
All claims are graded using the GRADE framework. Drug information is cross-referenced against official summaries of product characteristics (SmPC), regulatory agency publications, and peer-reviewed pharmacological research. Content is reviewed and updated at least every 6 months or when significant new evidence emerges.